In this article, we will discuss the 15 stocks that will go to the moon according to analysts.
The Stock Market Under Trump Admin
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico. He agreed to a 30-day pause on tariffs on Mexico and Canada in return for the two countries bolstering border enforcement to halt fentanyl smuggling and money laundering.
Reuters reported that Trump raising tariffs on steel and aluminum imports to a flat 25% pushed up share prices of US steelmakers. The chaos around tariffs doesn’t end here. According to CNN, the President is looking to pursue more tariffs. Trump has been keen on reciprocal tariffs and wants agencies to investigate plans for new reciprocal tariffs that would increase America’s revenue. He reiterated this keenness saying:
“They charge us a tax or tariff and we charge them the exact same”
These tariffs are expected to hit developing countries, especially India, Brazil, Vietnam, and other Southeast Asian and African countries, considering the large gap in tariff rates charged on US goods brought into these nations relative to what the United States charges them.
On February 14, the New York Times reported that global stock markets are holding up after Trump revealed his plan for reciprocal tariffs against all trading partners. While some countries such as Vietnam, India, and Taiwan have said that they would import specific US goods more, French winemakers are ramping up shipments to the country before levies. The threat of tariffs continues to result in uncertainty, regarding how they could be inflationary and potentially spook investors.
Sucharita Kodali, Retail Analyst at Forrester Research, appeared on CNBC to talk about the potential impact of tariffs on companies. In her opinion, all US companies would face some kind of challenges, with higher prices for both consumers as well as these firms. Based on her analysis, this is going to result in 20 basis points to a 150 basis points negative impact on the US GDP. Meanwhile, RBC’s Tom Narayan previously told CNBC that auto stocks will be the hardest hit by Trump’s Canada and Mexico tariffs, which are being deemed really inflationary and disruptive for the US auto consumer.
With that being said, let’s move to the 15 stocks that will go to the moon according to analysts.
A portfolio manager studying various stocks and other securities on a tablet.
Our Methodology:
We used a stock screener to find stocks which had the highest average upside potential (at least 25%), as of February 24. The 15 stocks that will go to the moon according to analysts have been arranged in ascending order of their average upside potential. Please note that we excluded penny stocks from our screening criteria. We have also mentioned the hedge fund sentiment for these stocks, as of Q4 2024.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
15 Stocks That Will Go to The Moon According to Analysts
15. Biogen Inc. (NASDAQ:BIIB)
Average Upside Potential: 25.50%
Number of Hedge Fund Holders: 52
Biogen Inc. (NASDAQ:BIIB) is a leading biotechnology company founded in 1978. The firm pioneers innovative science for delivering medicines to transform the lives of patients. Biogen’s therapies are available in over 80 countries.
While Biogen’s technology and engineering capabilities enable its high-quality medicines to come to market, its deep scientific expertise makes the firm a leader in the research and development of medicines. Biogen continues to execute its strategy for long-term sustainable growth while showcasing its innovation capabilities. The firm launched four first-in-class, disease-modifying products in key areas of Alzheimer’s, Friedreich’s ataxia, depression, and ALS (amyotrophic lateral sclerosis) last year while successfully lowering operating expenses to focus on growth investments.
RBC Capital has maintained an Outperform rating on the stock while lowering the price target from $231 to $225. According to the firm, Biogen streamlining its research and development priorities as well as optimizing expenses has resulted in a stronger core business structure. Recently, the stock also received a Buy from George Farmer from Scotiabank alongside a price target of $224.
14. Micron Technology, Inc. (NASDAQ:MU)
Average Upside Potential: 26.97%
Number of Hedge Fund Holders: 94
Micron Technology, Inc. (NASDAQ:MU) is a manufacturer and supplier of storage and memory products that began as a four-person semiconductor design company in 1978. The company has a portfolio of high-performance DRAM, NAND, and NOR memory and storage products through its Micron and Crucial brands.
Micron has been a global leader in innovative memory and storage solutions for more than 45 years. With advanced memory solutions, the company is in an attractive position amid rising AI and data center demand. Delaware Funds by Macquarie, an investment management company, released its “Delaware Ivy Core Equity Fund” Q3 2024 investor letter, stating the following:
“Micron Technology, Inc. (NASDAQ:MU) – Fundamentals here also appear solid though concern about global demand for handsets and PCs drove the shares down during the quarter. We expect Micron to be a significant beneficiary of growth in AI demand as investment in new data centers is extremely memory (semiconductor) intensive.”
Citi has reiterated a Buy rating on Micron Technology, Inc. (NASDAQ:MU), with a $150 price target. Micron stated at a conference that its May quarter gross margin is expected to decline by a few hundred basis points sequentially, short of the firm’s initial projection of a slight increase. Despite the disappointing guidance, the reasons for Citi’s optimism are based on the company’s artificial intelligence high bandwidth memory opportunity as well as a recovery for the DRAM market during the spring.
